Skip to content

Study · Non-randomized trial · n = 76 · 2013

4 results

Exploring the role of intra-nasal oxytocin on the partner preference effect in humans.

Liu JC, Guastella AJ, Dadds MR

Psychoneuroendocrinology21 Aug 2012Cited by 12 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In undergraduate students, oxytocin increased preference for persons introduced under the influence of oxytocin, versus placebo.

    In plain wordsIn students, oxytocin raised preference for people met while on oxytocin, compared with placebo.

    Peptide
    Oxytocin
    Outcome
    IncreasePreference for persons introduced under oxytocin
    Study

    n = 76

    Comparator
    Placebo
    Outcome group
    Social behavior and cognition · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We found evidence suggesting oxytocin increases preference for persons introduced under the influence of oxytocin
    1 context sentence
    Summary · context
    Seventy-six undergraduate students received either oxytocin or placebo before being introduced to a male and female persona (via pre-recorded videoclips).
  2. 02HumanNon-randomized trialEfficacy outcome

    In undergraduate students, the oxytocin-induced preference was not targeted at persons of the opposite gender.

    In plain wordsIn students, the preference raised by oxytocin was not aimed at people of the opposite gender.

    Peptide
    Oxytocin
    Outcome
    No significant changePartner preference toward opposite-gender persons
    Study

    n = 76

    Comparator
    Placebo
    Outcome group
    Social behavior and cognition · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    however, this was not targeted at persons of the opposite-gender
    1 context sentence
    Summary · context
    Seventy-six undergraduate students received either oxytocin or placebo before being introduced to a male and female persona (via pre-recorded videoclips).
  3. 03HumanNon-randomized trialEfficacy outcome

    In undergraduate students, oxytocin increased preference in one aspect of social interaction, finding out more information about the person.

    In plain wordsIn students, oxytocin raised the wish to find out more about a person met on oxytocin.

    Peptide
    Oxytocin
    Outcome
    IncreasePreference to find out more information about the person
    Study

    n = 76

    Comparator
    Placebo
    Outcome group
    Social behavior and cognition · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    was found in only one aspect of social interaction (finding out more information about the person
    1 context sentence
    Summary · context
    Seventy-six undergraduate students received either oxytocin or placebo before being introduced to a male and female persona (via pre-recorded videoclips).
  4. 04HumanNon-randomized trialEfficacy outcome

    In undergraduate students, oxytocin did not change the choice of company to work with or for a date.

    In plain wordsIn students, oxytocin did not change who they chose to work with or go on a date with.

    Peptide
    Oxytocin
    Outcome
    No significant changeChoice of company to work with or for a date
    Study

    n = 76

    Comparator
    Placebo
    Outcome group
    Social behavior and cognition · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    but not in choice of company to work with or for a date)
    1 context sentence
    Summary · context
    Seventy-six undergraduate students received either oxytocin or placebo before being introduced to a male and female persona (via pre-recorded videoclips).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:49 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.